NCT05798312View on ClinicalTrials.gov

Randomized and Multicenter Study to Evaluate a Customizable Support Breast Cancer Material

NACompletedINTERVENTIONAL
Enrollment

125

Participants

Timeline

Start Date

May 21, 2021

Primary Completion Date

March 13, 2022

Study Completion Date

March 13, 2022

Conditions
Breast CancerKnowledge, Attitudes, PracticePatient EmpowermentPatient Satisfaction
Interventions
OTHER

Customizable support material

Customizable support material will enable patients to identify their personal breast cancer information.

OTHER

Non-customizable support material

Non-customizable support material will include general breast cancer information.

Trial Locations (1)

66278

Hospital Zambrano Hellion, San Pedro Garza García

All Listed Sponsors
collaborator

Roche Pharma AG

INDUSTRY

lead

Medicos e Investigadores en la Lucha contra el Cancer de Mama

OTHER